Annual CFF:
$240.53M+$124.12M(+106.63%)Summary
- As of today, IMNM annual cash from financing is $240.53 million, with the most recent change of +$124.12 million (+106.63%) on December 31, 2024.
- During the last 3 years, IMNM annual cash from financing has risen by +$212.76 million (+766.21%).
- IMNM annual cash from financing is now at all-time high.
Performance
IMNM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$55.00K-$162.28M(-100.03%)Summary
- As of today, IMNM quarterly cash from financing is -$55.00 thousand, with the most recent change of -$162.28 million (-100.03%) on June 30, 2025.
- Over the past year, IMNM quarterly cash from financing has dropped by -$749.00 thousand (-107.93%).
- IMNM quarterly cash from financing is now -100.03% below its all-time high of $219.44 million, reached on March 31, 2024.
Performance
IMNM Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$182.56M-$749.00K(-0.41%)Summary
- As of today, IMNM TTM cash from financing is $182.56 million, with the most recent change of -$749.00 thousand (-0.41%) on June 30, 2025.
- Over the past year, IMNM TTM cash from financing has dropped by -$153.95 million (-45.75%).
- IMNM TTM cash from financing is now -45.75% below its all-time high of $336.51 million, reached on June 30, 2024.
Performance
IMNM TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IMNM Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +106.6% | -107.9% | -45.8% |
| 3Y3 Years | +766.2% | -100.0% | +10000.0% |
| 5Y5 Years | +2132.5% | - | - |
IMNM Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | -100.0% | at low | -45.8% | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | -100.0% | +71.8% | -45.8% | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | -100.0% | +71.8% | -45.8% | >+9999.0% |
IMNM Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$55.00K(-100.0%) | $182.56M(-0.4%) |
| Mar 2025 | - | $162.23M(+707.7%) | $183.31M(-23.8%) |
| Dec 2024 | $240.53M(+106.6%) | $20.09M(+6485.2%) | $240.53M(-12.8%) |
| Sep 2024 | - | $305.00K(-56.1%) | $275.94M(-18.0%) |
| Jun 2024 | - | $694.00K(-99.7%) | $336.51M(+0.2%) |
| Mar 2024 | - | $219.44M(+295.4%) | $335.82M(+188.5%) |
| Dec 2023 | $116.41M(>+9900.0%) | $55.50M(-8.8%) | $116.41M(+91.1%) |
| Sep 2023 | - | $60.88M(>+9900.0%) | $60.91M(>+9900.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $34.00K(0.0%) |
| Mar 2023 | - | $34.00K(>+9900.0%) | $34.00K(+6.3%) |
| Dec 2022 | $32.00K | $0.00(0.0%) | $32.00K(+119.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $0.00(0.0%) | -$163.00K(-138.6%) |
| Jun 2022 | - | $0.00(-100.0%) | $422.00K(-98.5%) |
| Mar 2022 | - | $32.00K(+116.4%) | $27.72M(-0.2%) |
| Dec 2021 | $27.77M(-44.4%) | -$195.00K(-133.3%) | $27.77M(-58.6%) |
| Sep 2021 | - | $585.00K(-97.9%) | $67.09M(+0.9%) |
| Jun 2021 | - | $27.30M(>+9900.0%) | $66.51M(+69.6%) |
| Mar 2021 | - | $76.00K(-99.8%) | $39.21M(-1.9%) |
| Dec 2020 | $49.94M(+363.6%) | $39.13M(+4536.3%) | $39.97M(+4636.3%) |
| Mar 2020 | - | $844.00K | $844.00K |
| Dec 2019 | $10.77M(+2055.4%) | - | - |
| Dec 2018 | -$551.00K | - | - |
FAQ
- What is Immunome, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Immunome, Inc.?
- What is Immunome, Inc. annual cash from financing year-on-year change?
- What is Immunome, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Immunome, Inc.?
- What is Immunome, Inc. quarterly cash from financing year-on-year change?
- What is Immunome, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Immunome, Inc.?
- What is Immunome, Inc. TTM cash from financing year-on-year change?
What is Immunome, Inc. annual cash from financing?
The current annual cash from financing of IMNM is $240.53M
What is the all-time high annual cash from financing for Immunome, Inc.?
Immunome, Inc. all-time high annual cash from financing is $240.53M
What is Immunome, Inc. annual cash from financing year-on-year change?
Over the past year, IMNM annual cash from financing has changed by +$124.12M (+106.63%)
What is Immunome, Inc. quarterly cash from financing?
The current quarterly cash from financing of IMNM is -$55.00K
What is the all-time high quarterly cash from financing for Immunome, Inc.?
Immunome, Inc. all-time high quarterly cash from financing is $219.44M
What is Immunome, Inc. quarterly cash from financing year-on-year change?
Over the past year, IMNM quarterly cash from financing has changed by -$749.00K (-107.93%)
What is Immunome, Inc. TTM cash from financing?
The current TTM cash from financing of IMNM is $182.56M
What is the all-time high TTM cash from financing for Immunome, Inc.?
Immunome, Inc. all-time high TTM cash from financing is $336.51M
What is Immunome, Inc. TTM cash from financing year-on-year change?
Over the past year, IMNM TTM cash from financing has changed by -$153.95M (-45.75%)